Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians

Sleep Initiation and Maintenance Disorders (F03.870.400.800.800); Sleep-Wake Transition Disorders (C10.886.659.700); Sleep-Wake Transition Disorders (F03.870.664.700); Doxepin (D02.355.291.852.500); Doxepin (D03.494.382.393); Drug Therapy (E02.319); Cognitive Therapy (F04.754.137.428); Behavior Therapy (F04.754.137); Relaxation Therapy (E02.190.525.875); Relaxation Therapy (F04.754.137.750); Psychotherapy (F04.754); Complementary Therapies (E02.190); Acupuncture (H02.004); Drugs; Chinese Herbal (D26.335); Drugs; Chinese Herbal (D20.215.784.500.350); Hypnotics and Sedatives (D27.505.954.427.210.350); Hypnotics and Sedatives (D27.505.696.277.350); Hypnotics and Sedatives (D27.505.696.410); Benzodiazepines (D03.438.079.080); Insomnia; Fatal Familial (C10.228.228.800.392); Insomnia; Fatal Familial (C10.886.425.800.800.400); Insomnia; Fatal Familial (C10.574.843.512); Sleep Disorders (C10.886); Sleep Disorders (C23.888.592.796); Sleep Disorders (F03.870); Sleep Initiation and Maintenance Disorders (C10.886.425.800.800)